CytoDyn Inc.(CYDY)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-28 | Mulholland Michael D. Chief Financial Officer | Sale | -711,801 | -71.47%284,081 | $6.23 | $4,437,557 | View SEC filing | |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Sale | -1,104,799 | -10.12%284,081 | $5.27 | $5,827,032 | View SEC filing | |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Sale | -1,108,799 | -10.12%284,081 | $5.28 | $5,849,360 | View SEC filing | |
| 2020-11-03 | Naydenov Jordan G Director | Purchase | +193,500 | +3.09%6,451,323 | $2.57 | $497,295 | View SEC filing | |
| 2020-10-26 | Colachis Arian GC and Corporate Secretary | Purchase | +10,000 | +14.29%80,000 | $2.50 | $25,000 | View SEC filing | |
| 2020-10-26 | Naydenov Jordan G Director | Purchase | +120,000 | +1.96%6,257,823 | $2.49 | $298,308 | View SEC filing | |
| 2020-05-15 | Kelly Scott A. Chairman & CMO | Sale | -1,200,000 | -43.51%1,557,718 | $3.26 | $3,912,480 | View SEC filing | |
| 2020-05-05 | Kelly Scott A. Chief Medical Officer | Mixed | -950,000 | -2.48%1,557,718 | $2.80 | $4,053,730 | View SEC filing | |
| 2020-05-04 | Pourhassan Nader President & CEO | Sale | -4,821,174 | -84.06%908,343 | $3.27 | $15,760,910 | View SEC filing | |
| 2020-02-04 | Welch David F Director | Purchase | +1,750,000 | +100.00%1,750,000 | $0.57 | $1,000,000 | View SEC filing | |
| 2019-01-10 | Klump Michael A Director | Purchase | +1,500,000 | +100.00%1,500,000 | N/A | N/A | View SEC filing | |
| 2016-10-21 | Pourhassan Nader President and CEO | Purchase | +15,000 | +2000.00%15,750 | $0.66 | $9,930 | View SEC filing | |
| 2016-10-17 | Mulholland Michael D. CFO, Treasurer and Secretary | Purchase | +11,000 | +42.24%37,043 | $0.66 | $7,238 | View SEC filing | |
| 2015-07-20 | Alpha Venture Capital Partners, L.P. 10% Owner | Purchase | +3,454,723 | +164.85%5,550,423 | $0.02 | $70,422 | View SEC filing | |
| 2015-07-15 | DOCKERY CARL Director, 10% Owner | Purchase | +2,454,723 | +76.75%5,653,265.436 | $0.03 | $70,422 | View SEC filing | |
| 2015-06-26 | DOCKERY CARL Director, 10% Owner | Purchase | +1,000,000 | +100.00%1,000,000 | N/A | N/A | View SEC filing | |
| 2014-10-31 | Caracciolo Anthony Director | Purchase | +26,000 | +41.84%88,136 | $0.72 | $18,720 | View SEC filing | |
| 2014-10-16 | Mulholland Michael D. CFO, Treasurer and Secretary | Purchase | +2,500 | +10.62%26,043 | $0.79 | $1,975 | View SEC filing | |
| 2012-09-21 | Dembow George F Director | Sale | -75,000 | -23.13%249,205 | $0.79 | $59,000 | View SEC filing | |
| 2012-05-09 | Dembow George F Director | Sale | -7,175 | -2.21%317,216 | $2.02 | $14,494 | View SEC filing | |
| 2012-05-03 | Dembow George F Director | Sale | -13,509 | -4.00%324,391 | $2.06 | $27,859 | View SEC filing | |
| 2012-04-30 | Van Ness Kenneth President & CEO | Sale | -1,396 | -0.07%1,927,645 | $2.10 | $2,932 | View SEC filing | |
| 2012-01-25 | Dembow George F Director | Sale | -30,000 | -8.16%337,500 | $2.71 | $81,300 | View SEC filing | |
| 2011-12-22 | CARACCIOLO ANTHONY Director | Purchase | +50,000 | +100.00%50,000 | $1.50 | $75,000 | View SEC filing | |
| 2011-11-03 | Dembow George F Director | Mixed | +42,500 | +11.32%417,900 | $0.50 | $28,825 | View SEC filing |
1-25 of 33